1. Agis-Balboa RC, Pinna G, Veldic M, Costa E, Guidotti A (2005) Brain region- and neuron-specific distribution of 5α-reductase type I (5α-RI) and 3α-hydroxysteroid-dehydrogenase (3α-HSD). Society for Neuroscience Abstract 35:261.12
2. Altamura AC, Moro AR, Percudani M (1994) Clinical pharmacokinetics of fluoxetine. Clin Pharmacokinet 26:201–214
3. Auta J, Romeo E, Kozikowski A, Ma D, Costa E, Guidotti A (1993) Participation of mitochondrial diazepam binding inhibitor receptor in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3-indoleacetamide and imidazopyridine derivatives. J Pharmacol Exp Ther 265:649–656
4. Barbaccia ML (2004) Neurosteroidogenesis: relevance to neurosteroid actions in brain and modulation by psychotropic drugs. Crit Rev Neurobiol 16:67–74
5. Barbaccia ML, Serra M, Purdy RH, Biggio G (2001) Stress and neuroactive steroids. Int Rev Neurobiol 46:243–272